SCHEMBL442562

SCHEMBL442562

C=CCCC(=O)NC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL29182400 0.93 LMNA (0.41)
SCHEMBL2426767 0.86
SCHEMBL3112322 0.84 ALDH1A1 (0.62)
SCHEMBL3111897 0.82 ALDH1A1 (0.66)
SCHEMBL454058 0.82 ALDH1A1 (0.66)
SCHEMBL3118175 0.82 ALDH1A1 (0.66)
SCHEMBL19772379 0.82 ALDH1A1 (0.66)
SCHEMBL3116505 0.82 ALDH1A1 (0.66)
SCHEMBL3117202 0.82 ALDH1A1 (0.66)
SCHEMBL25159763 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109689714-A Silicone hydrogels comprising N-alkylmethacrylamides and contact lenses made therefrom 庄臣及庄臣视力保护公司 2019-04-26 CN claimed
CN-103946325-B Aqueous coating compositions 湛新奥地利有限公司 2017-02-15 CN claimed
WO-2023229884-A2 3'-BLOCKED NUCLEOTIDES, METHODS OF DEBLOCKING THE SAME, AND METHODS OF SYNTHESIZING POLYNUCLEOTIDES USING THE SAME ILLUMINA, INC. (US) 2023-11-30 WO disclosed
CN-109689714-B Silicone hydrogels comprising N-alkylmethacrylamides and contact lenses made therefrom 庄臣及庄臣视力保护公司 2022-07-05 CN disclosed
CN-109415474-B Silicone hydrogels comprising high levels of polyamides 庄臣及庄臣视力保护公司 2022-05-10 CN disclosed
EP-3818129-A1 PROGRESSIVE SALTING-OUT OF POLYMER CHAINS IN A LIQUID MEDIUM RHODIA OPERATIONS (FR) 2021-05-12 EP disclosed
WO-2020161072-A1 PROCESS FOR MANUFACTURING QUANTUM DOTS UNIVERSITEIT VAN AMSTERDAM (NL) 2020-08-13 WO disclosed
EP-3693439-A1 METHOD FOR MANUFACTURING QUANTUM DOTS Universiteit van Amsterdam (NL) 2020-08-12 EP disclosed
US-20200131669-A1 CYCLIC PEPTIDE COMPOUND HAVING HIGH MEMBRANE PERMEABILITY, AND LIBRARY CONTAINING SAME CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2020-04-30 US disclosed
EP-3601228-A1 MICROBIOCIDAL QUINOLINE (THIO)CARBOXAMIDE DERIVATIVES Syngenta Participations AG (CH) 2020-02-05 EP disclosed
WO-2020007828-A1 PROGRESSIVE SALTING-OUT OF POLYMER CHAINS IN A LIQUID MEDIUM RHODIA OPERATIONS (FR) 2020-01-09 WO disclosed
WO-2007015855-A1 HCV NS3 PROTEASE INHIBITORS MERCK & CO., INC. (US) 2007-02-08 WO disclosed
US-20070027071-A1 HCV NS3 protease inhibitors MERCK SHARP & DOHME LLC 2007-02-01 US disclosed
US-20070027071-A1 HCV NS3 protease inhibitors MERCK SHARP & DOHME LLC 2007-02-01 US disclosed
US-20070027071-A1 HCV NS3 protease inhibitors MERCK SHARP & DOHME LLC 2007-02-01 US disclosed
EP-0680962-B1 Heterocyclic compounds ASTRAZENECA AB (SE) 2003-08-20 EP disclosed
EP-1265844-A1 METHOD FOR PRODUCING AMINES BY THE HYDROAMINOMETHYLATION OF OLEFINS IN THE PRESENCE OF IONIC LIQUIDS Bayer Aktiengesellschaft (DE) 2002-12-18 EP disclosed
EP-0734383-B1 CYCLIC AMIDE DERIVATIVES AS NEUROKININ A ANTAGONISTS ASTRAZENECA AB (SE) 2002-07-24 EP disclosed
WO-2001064621-A1 METHOD FOR PRODUCING AMINES BY THE HYDROAMINOMETHYLATION OF OLEFINS IN THE PRESENCE OF IONIC LIQUIDS BAYER AKTIENGESELLSCHAFT (DE) 2001-09-07 WO disclosed
US-4179292-A Light-sensitive copying composition HOECHST AKTIENGESELLSCHAFT (DE) 1979-12-18 US disclosed